Foseco India Q1 FY27 Results (NSE: FOSECOIND)
Signal: Steady quarter
The read
The filing points to a larger consolidated earnings base, with revenue ₹433.29 crore, EBITDA ₹108.01 crore and 24.9% margin, but the trajectory is increasingly acquisition-led: the Mehsana business purchase is ₹43.25 crore while consolidated PPE plus CWIP fell to ₹112.1424 crore and depreciation rose to ₹16.2820 crore for the half-year.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹433.29 Cr | N/A | N/A |
| EBIT | ₹91.73 Cr | N/A | |
| Net profit | ₹64.99 Cr | N/A | |
| EPS | ₹86.23 | N/A | |
| EBIT margin | 24.9% |
P&L walk
Consolidated revenue was ₹433.29 crore and EBITDA ₹108.01 crore at a 24.9% margin; PAT was ₹64.99 crore and EPS ₹86.23, but the supplied verified block provides no comparative growth fields for this basis.
Segments
The filing reports only one segment, metallurgical products and services, so no segment-level momentum split is available; the material group-versus-parent gap is consolidated revenue of ₹433.29 crore versus standalone revenue of ₹344.98 crore and consolidated PAT of ₹64.99 crore versus standalone PAT of ₹46.82 crore.
Key positives
- Consolidated EBITDA was ₹108.01 crore at a 24.9% margin, while standalone EBITDA rose 15.2% YoY to ₹72.69 crore.
- Standalone revenue grew 12.8% YoY to ₹344.98 crore and EBIT grew 16.3% YoY to ₹67.85 crore, showing positive operating momentum.
- Consolidated operating cash flow was ₹70.2476 crore for the six months versus ₹46.9932 crore previously, despite higher receivables and inventories.
- Cash and cash equivalents increased to ₹138.6685 crore from ₹96.7925 crore at 31 December 2025, supporting the proposed ₹43.25 crore acquisition.
Key concerns
- Standalone PAT growth of 8.4% to ₹46.82 crore lagged EBITDA growth of 15.2% to ₹72.69 crore, while EPS fell 8.2% to ₹62.12.
- Trade receivables rose to ₹164.5595 crore and inventories to ₹69.0783 crore from ₹153.3967 crore and ₹52.6226 crore respectively, absorbing working capital.
- The proposed Mehsana acquisition costs ₹43.25 crore, creating integration and return-on-invested-capital execution risk.
Research and educational content only. Not investment advice.